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Methods for biological diagnosis of plague
Biological samples were collected by healthcare workers or physicians from suspected plague cases. Samples were mainly bubo aspirates for bubonic plague (BP), sputum for pneumonic plague (PP) and liver or lung puncture for plague-suspected deceased cases. Before this epidemic, the diagnostic algorithm from the Central Laboratory for Plague required that each biological sample was tested for fraction 1 (F1) capsular antigen using rapid diagnostic test (RDT) 1 and only positive RDTs were confirmed by culture for Yersinia pestis isolation. 2 Additionally, conventional PCR targeting the pla gene 3, 4 was introduced at the beginning of this epidemic given the low yield of microbiological culture on sputum samples compared to bubo samples. However, it became apparent that this PCR lacked specificity and a real time PCR (qPCR) was implemented using pla and caf1 genes (adapted from Loïez et al. 5 ) to gain time and specificity . Further, a conventional PCR targeting pla, caf1 and inv genes (adapted from Tsukano et al. 6 ) was implemented and used to confirm discordant (only one gene positive by qPCR) or uncertain qPCR results ( Figure S1 ). Detailed information will be provided in a separate paper regarding the performance of these tests when serological studies to confirm infections have been completed in a subset of recovered patients. The algorithm for the diagnosis of plague cases by molecular biology, combining qPCR and conventional PCR, is shown in Supplementary Figure S1 . The results of the three types of diagnostic tests (RDT, molecular biology, and culture) were then used to classify cases as suspected, probable, and confirmed, as detailed in Table 1 . 
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Additional descriptions of plague cases
Plague cases with unspecified clinical forms
During the epidemic, 140 cases with unspecified clinical forms were identified (Table S1 ). 
Confirmed/probable plague cases
Characteristics of the combined group of confirmed/probable cases by clinical form are presented in Table S2 . 
Post-mortem tissue sampling
Post-mortem tissue samples were obtained from 42 PP cases and 7 BP cases (Table S3) . We performed a survival analysis to assess potential effects of censoring (e.g., deaths that occurred after case reporting) on case fatality estimates. Survival probability was estimated based on a generalization of the KaplanMeier curve (non-parametric maximum likelihood estimator) allowing for right censoring (deaths that occurred after case reporting) and interval censoring (deaths with unknown date of death between onset date and reporting date) ( Figure 2 ). We used imputed onset dates for 14 PP cases (including six deaths) and two BP cases. One survivor (BP) with missing onset date and one death (unspecified clinical form) with missing death and reporting date were excluded from the analysis as the follow-up time could not be estimated. The difference in survival probability estimates among confirmed/probable cases was negligible when taking censoring into account; it increased from 9% to 12% for PP cases and from 15% to 16% for BP cases. As no important censoring effects were observed, and as the use of survival analysis methods such as Cox proportional hazards model requires assumptions to be fulfilled, we decided to investigate trends in risk factors for death among confirmed cases by estimating CFRs by case characteristics with exact binomial 95%CIs and among confirmed/probable cases by estimating relative risks of death using a log-binomial regression model.
Potential effects of inclusion of cases with unspecified clinical form on CFR estimates
Among confirmed/probable cases, 39/597 cases had unspecified clinical form of whom 19 had a reported fatal outcome. To investigate how cases with unspecified clinical form may have influenced CFR estimates, we assigned these cases to either (i) PP or (ii) BP clinical forms. If all cases with unspecified clinical form were PP cases, the CFR for PP increased from 9% to 13% (confirmed: 25% to 35%, probable 8% to 11%); if all these cases were BP cases the CFR for BP increased from 15% to 25% (confirmed: 24% to 30%, probable 6% to 21%). Among confirmed PP cases, the difference in the risk of death between cases with and without chest pain was smaller when cases with unspecified clinical form were included (without chest pain 29% vs. with chest pain 44%), as was the difference between cases with and without hemoptysis (without hemoptysis 33% vs. with hemoptysis 40%). The risk of death increased with time to clinical examination (0-1 days 19% vs. 2-4 days 54%) and was higher in the endemic zone than in Antananarivo area (67% vs. 17%). Among confirmed BP cases, the risk increased with time to clinical examination (0-1 days 13% vs. 2-4 days 45%), same as in the main analysis. We further identified the same risk factors associated with death among confirmed/probable cases as in the main analysis. 
CFR by type of probable cases
PP and BP cases were classified as probable cases if either (i) the rapid diagnostic test (RDT) or (ii) the molecular biology diagnosis is positive. Here we assessed the CFR among probable cases according to which diagnostic test led to the classification as probable cases. CFR estimates for probable cases were comparable regardless of which diagnostic test was positive (Table S4) . 
Case fatality risk factors among confirmed and confirmed/probable cases
Among confirmed PP cases, the risk of death tended to be higher among cases with chest pain than others (7/16 (44%) vs. 1/16 (6%)), among cases with haemoptysis than others (6/15 (40%) vs. 2/16 (12%)) and among cases in the endemic zone compared to Antananarivo area (5/10 (50%) vs. 3/18 (17%)) (Table S5 ). Among confirmed BP cases, the risk of death tended to increase with time to clinical examination (0 to 1 day 5/35 (13%) vs. 2 to 4 days 8/20 (40%)) (Table S5) .
We investigated risk factors of death among confirmed/probable PP and BP cases using a log-binomial regression model. For confirmed/probable PP cases, the risk of death was higher among cases in the endemic zone than in Antananarivo (relative risk RR 2.3, 95%CI 1.1 to 4.8) and was highest among ≥ 50 year-old cases (relative risk RR 3.8, 95% CI, 1.9 to 7.8; reference group: 15-49 year-old) ( Table S6 ). The risk of death was only minimally higher among confirmed/probable cases with chest pain compared to confirmed/probable cases without that symptom (RR 1.2, 95%CI 0.6 to 2.4) or confirmed/probable cases with haemoptysis compared to those without that symptom (RR 1.5, 95%CI 0.8 to 3.1). For confirmed/probable BP cases, the risk of death increased with time to clinical examination (RR 3.2, 95%CI, 1.2 to 8.1; 2-4 vs. 0-1 days delay) (Table S6) .
Disagreement in risk factors of death among confirmed and confirmed/probable cases, such as for PP cases with chest pain, may originate from the small number of notified confirmed cases, but may also indicate that not all probable cases were infected with Y. pestis. The higher risk of death among >50 year-old confirmed/probable PP cases may for example be related to other respiratory infections. # : cases without any reported treatment likely include cases with missing information. £ : geographical zones were classified as Antananarivo area (Urban Community of Antananarivo and the three neighbouring districts), Toamasina district, endemic zones 7, 8 (apart from Antananarivo area) and others.
Epidemic dynamics
Estimation of the exponential growth rate, the doubling time and the reproduction number
We used a simple exponential growth model to compute the doubling time (i.e. the time it takes for the number of cases to double) of confirmed/probable and confirmed cases in the growing phase of the PP epidemic, for the whole country and for Antananarivo area. 9 Let's assume that the serial interval (i.e. the average delay between symptom onset in the infector and in the secondary case) for PP was 4 days. If we also assumed that reporting of cases was stable during the epidemic, we could derive an estimate of the reproduction number of PP (i.e. the average number of persons infected by a PP case) 9 from this exponential growth model. In practice, however, it is likely that reporting increased over time and as a consequence, we expect our analysis will produce an upper bound of the true reproduction number. We investigated the sensitivity of our estimates to the assumed serial interval.
Methods:
We fitted a simple exponential growth rate model to the early stage of the epidemic (September 13-October 9, 2017) for the whole island and for Antananarivo area:
where is the number of cases on day t. The exponential growth rate r was estimated with a Poisson regression.
The doubling time D can be derived from the exponential growth rate with the following formula:
Denote (. ) the density of the serial interval (i.e. time lag from onset of a case to onset of the persons they infect).
The following formula can be used to derive the reproduction number R from the exponential growth rate and density (. ):
Nishiura estimated the serial interval of PP in a large outbreak in Manchuria in 1910-1911 at 5.7 days (coefficient of variation (CV): 0.6). 10 However, the epidemiology of PP at the start of the 20 th century in Manchuria is expected to be substantially different than in modern Madagascar, where the massive distribution of treatments and contact tracing measures should have substantially shortened the serial interval. For these reasons, in our baseline scenario, we followed expert opinion and assumed that the serial interval of PP in this epidemic followed a Gamma distribution with mean 4 days (CV: 0.6). In a sensitivity analysis, we varied the mean serial interval from 3 to 6 days. Figure S2 shows the fit of the exponential growth model to confirmed/probable case counts. Between September 13 and October 9, 2017, we estimate that the number of confirmed/probable PP cases doubled on average every 5 days (95% CI: 4, 6) for both the whole island and the Antananarivo area. Table S7 presents estimates of the reproduction number under the assumption that reporting of cases was stable during this epidemic and for different values of the serial interval. In the baseline scenario of a serial interval SI of 4 days, the reproduction number was estimated at 1.6 (95% CI: 1.5, 1.8) for the whole island. Estimates varied with the assumed serial interval from 1.5 (95% CI: 1.4, 1.5) for SI=3 days to 2.0 (95% CI: 1.8, 2.2) for SI=6 days. Estimates for Antananarivo area were comparable although slightly higher than those for the whole island. These estimates of the reproduction number can be interpreted as upper bounds because reporting is likely to have increased over time.
Results:
When restricting the analysis to confirmed cases, the doubling time increases to 9 (95% CI: 4, 50) days for Madagascar and 7 days (95% CI: 3, 287) for Antananarivo, but with very large confidence intervals. The upper bound for the reproduction number is then 1.4 (95% CI: 1.1, 1.8) for Madagascar and 1.4 (95% CI: 1.0, 2.0) for Antananarivo.
While we focused here on the early start of the epidemic to characterize doubling times and reproduction numbers, it will be interesting to model the rest of the epidemic curve in future analyses. Figure S3 presents the spatio-temporal distribution of confirmed/probable cases. 
Spatio-temporal distribution of confirmed/probable cases
Spatial autocorrelation and hotspots
Methods:
We quantified the degree of spatial autocorrelation of incidence (number of cases by inhabitant) between commune centroids by computing Moran's I. 11 As the small number of confirmed cases resulted in low statistical power to investigate spatial patterns at the commune level (sub-district administrative divisions, n=1578), we focused the spatial analysis on confirmed/probable cases. We estimated how the spatial correlation changed as a function of distance using a non-parametric spatial correlation function with bootstrap 95% confidence intervals (CI). 12 We further identified epidemic hotspots of PP as at least two confirmed/probable cases in the same commune, with no more than 12 days between the dates of symptom onset of two consecutive cases. Geographic and demographic data were obtained from the United Nations Office for the Coordination of Humanitarian Affairs.
Results: PP incidence exhibited positive spatial autocorrelation (Moran's I=0.20; p=0.01), indicating spatial clustering. The correlation decreased with the distance and was no longer significantly different from zero for communes separated by ≥ 21 km. In contrast, for BP, the spatial autocorrelation was not significant (Moran's I=0.01; p=0.1) and did not vary with distance ( Figure S4 ).
PP transmission hotspots were identified in 34 communes: 22 (65%) communes located in Antananarivo area, four (12%) in neighbouring regions of Antananarivo area, six (18%) in or close to Toamasina, and two (6%) in the South, which only contained 2 cases each ( Figure S4 ). The median number of cases per hotspot was 3 (IQR, 2 to 8), reaching 47 cases in one commune of Antananarivo. Altogether, the communes with hotspots contained 15% of the Malagasy population but 74% of confirmed/probable PP cases, indicating a high degree of clustering. 
